A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections

被引:11
作者
Lu, Qiong [1 ]
Zhu, Hai-Hong [1 ]
Li, Guo-Hua [1 ]
Qi, Ting-Ting [1 ]
Ye, Liang-Jun [2 ]
Teng, Xin-Qi [1 ]
Qu, Qiang [3 ]
He, Ge-Fei [4 ]
Qu, Jian [1 ]
机构
[1] Cent South Univ, Inst Clin Pharm, Xangya Hosp 2, Dept Pharm, Changsha, Peoples R China
[2] Hunan Prov Corps Hosp Chinese Peoples Armed Polic, Dept Pharm, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
[4] First Hosp Changsha, Dept Pharm, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
polymyxin B; carbapenem-resistant organisms; tigecycline; microbiological efficacy; bacteria clearance;
D O I
10.3389/fmed.2021.620885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The emergence of carbapenem-resistant gram-negative bacteria (CR-GNB) has brought great challenges to clinical anti-infection treatment around the world. Polymyxins are often considered as the last line of defense in the treatment of CR-GNB infections. In this study, we explored the microbiological efficacy of Polymyxin B (PMB) on different CR-GNB infections as well as the factors influencing microbiological efficacy. Methods: CR-GNB infected patients with PMB-based regimens were enrolled. Clinical and microbiological data were collected from the medical electronic record system of the Second Xiangya hospital. The efficacy of PMB on different CR-GNB was evaluated by the clearance rate at 7-days and within the course of treatment, as well as the 30-day mortality rate. Results: A total of 294 CR-GNB infected patients were enrolled: 154 CR-Acinetobacter baumannii (CRAB), 55 CR-Klebsiella pneumoniae (CRKP), and 85 CR-Pseudomonas aeruginosa (CRPA). The CRAB group had the highest 7-day bacterial clearance rate [(CRAB: 39.0%) vs. (CRKP: 29.4%) vs. (CRPA: 14.5%), P = 0.003] and total bacterial clearance rate [(CRAB: 49.0%) vs. (CRKP: 39.8%) vs. (CRPA: 18.2%), P < 0.001] among the three groups, while the bacterial clearance rate of the CRPA group was the lowest. Multivariate logistic regression showed that the differences among the three groups were multiple CR-GNB infections (P = 0.004), respiratory infections (P = 0.001), PMB resistance (P < 0.001), and the combination of tigecycline (P < 0.001). Binary logistic regression showed that multiple CR-GNB infection [(7-day bacterial clearance: P = 0.004) & (total bacterial clearance: P = 0.011)] and bacterial species [(7-day bacterial clearance: P < 0.001) & (total bacterial clearance: P < 0.001)] were independent risk factors for microbiological efficacy. Conclusion: PMB exhibited differential microbiological efficacy on different types of CR-GNB infections; it had the best effect on CRAB, followed by CRKP and CRPA. Multiple CR-GNB infections and bacterial species were independent risk factors for microbiological efficacy.
引用
收藏
页数:9
相关论文
共 35 条
  • [1] Synergy of polymyxin B, tigecycline and meropenem against carbapenem-resistant Enterobacter cloacae complex isolates
    Alves, Paola Hoff
    Boff, Roberta Taufer
    Barth, Afonso Luis
    Martins, Andreza Francisco
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (01) : 81 - 85
  • [2] [Anonymous], 2016, J Hosp Infect, V92, P99
  • [3] Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis
    Borjan, Jovan
    Meyer, Kevin A.
    Shields, Ryan K.
    Wenzler, Eric
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (01)
  • [4] Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections-A Cohort Study
    Cai, Yiying
    Leck, Hui
    Tan, Ray W.
    Teo, Jocelyn Q.
    Lim, Tze-Peng
    Lee, Winnie
    Chlebicki, Maciej Piotr
    Kwa, Andrea L.
    [J]. ANTIBIOTICS-BASEL, 2020, 9 (08): : 1 - 10
  • [5] Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model
    Cai, Yiying
    Lim, Tze-Peng
    Teo, Jocelyn Qi-Min
    Sasikala, Suranthran
    Chan, Eric Chun Yong
    Hong, Yan Jun
    Lee, Winnie
    Tan, Thean Yen
    Tan, Thuan Tong
    Koh, Tse Hsien
    Hsu, Li Yang
    Kwa, Andrea L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [6] Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Methods for Determining the Susceptibilities of Candida isolates
    Cilo, Burcu Dalyan
    Topac, Tuncay
    Agca, Harun
    Saglam, Sezcan
    Efe, Kadir
    Ener, Beyza
    [J]. MIKROBIYOLOJI BULTENI, 2018, 52 (01): : 35 - 48
  • [7] Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa
    da Costa Junior, Sergio Dias
    da Silva, Wagner Roberto Cirilo
    da Silva, Adriana Maria Costa Marques
    Maciel, Maria Amelia Vieira
    Cavalcanti, Isabella Macario Ferro
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [8] Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
    Dubrovskaya, Yanina
    Chen, Ting-Yi
    Scipione, Marco R.
    Esaian, Diana
    Phillips, Michael S.
    Papadopoulos, John
    Mehta, Sapna A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5394 - 5397
  • [9] El-Shaer S., 2017, PERFORMANCE STANDARD
  • [10] EUCAST, 2020, CLIN BREAKP BACT V 1